drugset / Trial / NCT01117051
Prucalopride Effects on Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced Constipation
RandomizedParallel-groupDouble-blindTreatment
Summary
The study will evaluate the efficacy, safety and tolerability of prucalopride over 12 weeks of treatment in subjects aged 18 years and older with chronic non-cancer pain, suffering from opioid induced constipation.
Timeline
- Start
- 2010-05-19
- Primary completion
- 2012-08-13
- Completion
- 2012-08-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prucalopride | Small molecule | 1 mg | — |
| Comparator | Prucalopride | Small molecule | 2 mg | — |